Human factors engineering for medical devices: European regulation and current issues

被引:11
|
作者
Pelayo, Sylvia [1 ,2 ]
Marcilly, Romaric [1 ,2 ]
Bellandi, Tommaso [3 ]
机构
[1] Univ Lille, CHU Lille, Inst Coeur Poumon, ULR Metr Evaluat Technol Sante & Prat Med 2694, Bld Prof J Leclercg, F-59000 Lille, France
[2] INSERM CIC IT 1403, Ctr Invest Clin Innovat Technol, Inst Coeur Poumon, Bld Prof J Leclercg, F-59000 Lille, France
[3] Reg Ctr Clin Risk Management & Patient Safety, Via Taddeo Alderotti 26-N, I-50100 Florence, Italy
关键词
ergonomics; risk; human factors; medical device; HEALTH-CARE; SYSTEM;
D O I
10.1093/intqhc/mzaa103
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
A large proportion of the patient injuries or deaths attributable to medical device (MD) misuse can be eliminated and/or mitigated by adopting an effective human factors and ergonomics (HFE) approach. The implementation of a usability engineering process is now mandatory for MD manufacturers seeking to obtain the European Union's CE Mark. Here, we describe the European Union's HFE regulation and highlight the challenges faced by (i) manufacturers implementing this regulation and (ii) regulatory bodies charged with assessing the compliance of usability files. In Europe, 95% of MD manufacturers are small- and medium-sized enterprises; compliance with the CE Mark regulations is a real challenge to their competitiveness. Levels of knowledge about HFE vary greatly from one regulatory organization to another, which can sometimes lead to very different expectations. We also present the specific use-related risk management approach required by the HFE regulation. Lastly, we focus on the limitations of the HFE regulation for MDs and on future HFE challenges in further reducing and/or eliminating MD use errors. The main challenge is the need to go beyond technology design and the premarket assessment and to look at the postproduction stage; the coupling between an MD and a sociotechnical system can lead to consequences that were not predicted during the design process. This implies the need to consider the emerging properties of technologies in use by involving all the stakeholders.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [1] Current issues in the regulation of human tissue-engineering products in the European Union
    Heinonen, M
    Oila, O
    Nordström, K
    [J]. TISSUE ENGINEERING, 2005, 11 (11-12): : 1905 - 1911
  • [2] Do it by design. Human factors issues in medical devices
    Doyle D.J.
    [J]. Canadian Journal of Anesthesia, 2000, 47 (12): : 1259 - 1260
  • [3] Regulation of medical devices in the European Union
    Chai, J
    [J]. JOURNAL OF LEGAL MEDICINE, 2000, 21 (04) : 537 - 556
  • [4] REGULATION OF MEDICAL DEVICES IN THE EUROPEAN COMMUNITY
    KINGHAM, RF
    [J]. FOOD AND DRUG LAW JOURNAL, 1992, 47 (05): : 563 - 570
  • [5] New European Regulation for Medical Devices
    Martelli, Nicolas
    Eskenazy, Deborah
    Narayanan, Kumar
    Lafont, Antoine
    Marijon, Eloi
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 (10) : 960 - 961
  • [6] Current Status of the Regulation for Medical Devices
    Shah, Anuja R.
    Goyal, R. K.
    [J]. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 70 (06) : 695 - 700
  • [7] MEDICAL DEVICES - CURRENT FOOD AND DRUG ADMINISTRATION ISSUES
    PILOT, LR
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1985, 190 (SEP): : 18 - CHL
  • [8] Current Challenges and Issues in Indian Regulations of Medical Devices
    Bhatia, Rohit
    Singh, Shubham
    Parashar, Ananya
    Thakkar, Arti R.
    [J]. CURRENT DRUG THERAPY, 2024, 19 (05) : 489 - 502
  • [9] Regulation of immunologicals in the European union: Current and emerging issues
    Kriz, NG
    [J]. BIOLOGICALS, 2005, 33 (04) : 247 - 252
  • [10] New European Regulation for Medical Devices: What Is Changing?
    Nicolas Martelli
    Déborah Eskenazy
    Carole Déan
    Judith Pineau
    Patrice Prognon
    Gilles Chatellier
    Marc Sapoval
    Olivier Pellerin
    [J]. CardioVascular and Interventional Radiology, 2019, 42 : 1272 - 1278